Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1997 Mar;76(2):F128–F133. doi: 10.1136/fn.76.2.f128

Haemopoietic colony stimulating factors for preterm neonates

R Carr, N Modi
PMCID: PMC1720631  PMID: 9135294

Full Text

The Full Text of this article is available as a PDF (108.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addison I. E., Johnson B., Devereux S., Goldstone A. H., Linch D. C. Granulocyte-macrophage colony-stimulating factor may inhibit neutrophil migration in vivo. Clin Exp Immunol. 1989 May;76(2):149–153. [PMC free article] [PubMed] [Google Scholar]
  2. Aglietta M., Monzeglio C., Sanavio F., Aprá F., Morelli S., Stacchini A., Piacibello W., Bussolino F., Bagnara G., Zauli G. In vivo effect of human granulocyte-macrophage colony-stimulating factor on megakaryocytopoiesis. Blood. 1991 Mar 15;77(6):1191–1194. [PubMed] [Google Scholar]
  3. Al-Hadithy H., Addison I. E., Goldstone A. H., Cawley J. C., Shaw J. C. Defective neutrophil function in low-birth-weight, premature infants. J Clin Pathol. 1981 Apr;34(4):366–370. doi: 10.1136/jcp.34.4.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Babior B. M. The respiratory burst of phagocytes. J Clin Invest. 1984 Mar;73(3):599–601. doi: 10.1172/JCI111249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bailie K. E., Irvine A. E., Bridges J. M., McClure B. G. Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery. Pediatr Res. 1994 Feb;35(2):164–168. doi: 10.1203/00006450-199402000-00007. [DOI] [PubMed] [Google Scholar]
  6. Baley J. E., Stork E. K., Warkentin P. I., Shurin S. B. Neonatal neutropenia. Clinical manifestations, cause, and outcome. Am J Dis Child. 1988 Nov;142(11):1161–1166. doi: 10.1001/archpedi.1988.02150110039016. [DOI] [PubMed] [Google Scholar]
  7. Barbour A. G., Allred C. D., Solberg C. O., Hill H. R. Chemiluminescence by polymorphonuclear leukocytes from patients with active bacterial infection. J Infect Dis. 1980 Jan;141(1):14–26. doi: 10.1093/infdis/141.1.14. [DOI] [PubMed] [Google Scholar]
  8. Bedford Russell A. R., Davies E. G., Gibson F. M., Gordon-Smith E. C. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells. Pediatr Res. 1995 May;37(5):630–633. doi: 10.1203/00006450-199505000-00013. [DOI] [PubMed] [Google Scholar]
  9. Bodey G. P., Anaissie E., Gutterman J., Vadhan-Raj S. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin Infect Dis. 1993 Oct;17(4):705–707. doi: 10.1093/clinids/17.4.705. [DOI] [PubMed] [Google Scholar]
  10. Bonilla M. A., Dale D., Zeidler C., Last L., Reiter A., Ruggeiro M., Davis M., Koci B., Hammond W., Gillio A. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol. 1994 Dec;88(4):723–730. doi: 10.1111/j.1365-2141.1994.tb05110.x. [DOI] [PubMed] [Google Scholar]
  11. CARTWRIGHT G. E., ATHENS J. W., WINTROBE M. M. THE KINETICS OF GRANULOPOIESIS IN NORMAL MAN. Blood. 1964 Dec;24:780–803. [PubMed] [Google Scholar]
  12. Cairo M. S., Christensen R., Sender L. S., Ellis R., Rosenthal J., van de Ven C., Worcester C., Agosti J. M. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. Blood. 1995 Oct 1;86(7):2509–2515. [PubMed] [Google Scholar]
  13. Cairo M. S., Mauss D., Kommareddy S., Norris K., van de Ven C., Modanlou H. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Pediatr Res. 1990 Jun;27(6):612–616. doi: 10.1203/00006450-199006000-00016. [DOI] [PubMed] [Google Scholar]
  14. Cairo M. S., Mauss D., Plunkett J. M., Gillis S., van de Ven C. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3. Pediatr Res. 1991 May;29(5):504–509. doi: 10.1203/00006450-199105010-00018. [DOI] [PubMed] [Google Scholar]
  15. Cairo M. S., Plunkett J. M., Mauss D., Van de ven C. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis. Blood. 1990 Nov 1;76(9):1788–1794. [PubMed] [Google Scholar]
  16. Cairo M. S., Suen Y., Knoppel E., Dana R., Park L., Clark S., van de Ven C., Sender L. Decreased G-CSF and IL-3 production and gene expression from mononuclear cells of newborn infants. Pediatr Res. 1992 Jun;31(6):574–578. doi: 10.1203/00006450-199206000-00007. [DOI] [PubMed] [Google Scholar]
  17. Cairo M. S., Suen Y., Knoppel E., van de Ven C., Nguyen A., Sender L. Decreased stimulated GM-CSF production and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns compared with adults. Pediatr Res. 1991 Oct;30(4):362–367. doi: 10.1203/00006450-199110000-00013. [DOI] [PubMed] [Google Scholar]
  18. Cairo M. S. Therapeutic implications of dysregulated colony-stimulating factor expression in neonates. Blood. 1993 Oct 15;82(8):2269–2272. [PubMed] [Google Scholar]
  19. Cairo M. S., van de Ven C., Mauss D., Kommareddy S., Norris K., Sheikh K., Modanlou H. Modulation of neonatal rat myeloid kinetics resulting in peripheral neutrophilia by single pulse administration of Rh granulocyte-macrophage colony-stimulating factor and Rh granulocyte colony-stimulating factor. Biol Neonate. 1991;59(1):13–21. doi: 10.1159/000243317. [DOI] [PubMed] [Google Scholar]
  20. Cairo M. S., van de Ven C., Toy C., Mauss D., Sender L. Recombinant human granulocyte-macrophage colony-stimulating factor primes neonatal granulocytes for enhanced oxidative metabolism and chemotaxis. Pediatr Res. 1989 Nov;26(5):395–399. doi: 10.1203/00006450-198911000-00001. [DOI] [PubMed] [Google Scholar]
  21. Cannistra S. A., Griffin J. D. Regulation of the production and function of granulocytes and monocytes. Semin Hematol. 1988 Jul;25(3):173–188. [PubMed] [Google Scholar]
  22. Cannistra S. A., Vellenga E., Groshek P., Rambaldi A., Griffin J. D. Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood. 1988 Mar;71(3):672–676. [PubMed] [Google Scholar]
  23. Carr R., Davies J. M. Abnormal FcRIII expression by neutrophils from very preterm neonates. Blood. 1990 Aug 1;76(3):607–611. [PubMed] [Google Scholar]
  24. Carr R., Huizinga T. W., Kleijer M., Davies J. M. Changes in plasma FcRIII demonstrate increasing receptor production during late pregnancy and after preterm birth. Pediatr Res. 1992 Nov;32(5):505–508. doi: 10.1203/00006450-199211000-00001. [DOI] [PubMed] [Google Scholar]
  25. Carr R., Pumford D., Davies J. M. Neutrophil chemotaxis and adhesion in preterm babies. Arch Dis Child. 1992 Jul;67(7 Spec No):813–817. doi: 10.1136/adc.67.7_spec_no.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Christensen R. D. Developmental changes in pluripotent hematopoietic progenitors. Early Hum Dev. 1988 Mar;16(2-3):195–205. doi: 10.1016/0378-3782(88)90099-0. [DOI] [PubMed] [Google Scholar]
  27. Christensen R. D., Harper T. E., Rothstein G. Granulocyte-macrophage progenitor cells in term and preterm neonates. J Pediatr. 1986 Dec;109(6):1047–1051. doi: 10.1016/s0022-3476(86)80297-9. [DOI] [PubMed] [Google Scholar]
  28. Christensen R. D., Liechty K. W., Koenig J. M., Schibler K. R., Ohls R. K. Administration of erythropoietin to newborn rats results in diminished neutrophil production. Blood. 1991 Sep 1;78(5):1241–1246. [PubMed] [Google Scholar]
  29. Christensen R. D., MacFarlane J. L., Taylor N. L., Hill H. R., Rothstein G. Blood and marrow neutrophils during experimental group B streptococcal infection: quantification of the stem cell, proliferative, storage and circulating pools. Pediatr Res. 1982 Jul;16(7):549–553. doi: 10.1203/00006450-198207000-00011. [DOI] [PubMed] [Google Scholar]
  30. Christensen R. D. Neutrophil kinetics in the fetus and neonate. Am J Pediatr Hematol Oncol. 1989 Summer;11(2):215–223. [PubMed] [Google Scholar]
  31. Christensen R. D., Rothstein G. Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr. 1980 Feb;96(2):316–318. doi: 10.1016/s0022-3476(80)80837-7. [DOI] [PubMed] [Google Scholar]
  32. Christensen R. D., Rothstein G. Pre- and postnatal development of granulocytic stem cells in the rat. Pediatr Res. 1984 Jul;18(7):599–602. doi: 10.1203/00006450-198407000-00006. [DOI] [PubMed] [Google Scholar]
  33. Dale D. C., Bonilla M. A., Davis M. W., Nakanishi A. M., Hammond W. P., Kurtzberg J., Wang W., Jakubowski A., Winton E., Lalezari P. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood. 1993 May 15;81(10):2496–2502. [PMC free article] [PubMed] [Google Scholar]
  34. Davis I., Morstyn G. Clinical uses of growth factors. Baillieres Clin Haematol. 1992 Jul;5(3):753–786. doi: 10.1016/s0950-3536(11)80016-8. [DOI] [PubMed] [Google Scholar]
  35. Dong F., Brynes R. K., Tidow N., Welte K., Löwenberg B., Touw I. P. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med. 1995 Aug 24;333(8):487–493. doi: 10.1056/NEJM199508243330804. [DOI] [PubMed] [Google Scholar]
  36. Driscoll M. S., Thomas V. L., Ramamurthy R. S., Casto D. T. Longitudinal evaluation of polymorphonuclear leukocyte chemiluminescence in premature infants. J Pediatr. 1990 Mar;116(3):429–434. doi: 10.1016/s0022-3476(05)82838-0. [DOI] [PubMed] [Google Scholar]
  37. Eisenfeld L., Krause P. J., Herson V., Savidakis J., Bannon P., Maderazo E., Woronick C., Giuliano C., Banco L. Longitudinal study of neutrophil adherence and motility. J Pediatr. 1990 Dec;117(6):926–929. doi: 10.1016/s0022-3476(05)80139-8. [DOI] [PubMed] [Google Scholar]
  38. Emmerson A. J., Coles H. J., Stern C. M., Pearson T. C. Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child. 1993 Mar;68(3 Spec No):291–296. doi: 10.1136/adc.68.3_spec_no.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. English B. K., Hammond W. P., Lewis D. B., Brown C. B., Wilson C. B. Decreased granulocyte-macrophage colony-stimulating factor production by human neonatal blood mononuclear cells and T cells. Pediatr Res. 1992 Mar;31(3):211–216. doi: 10.1203/00006450-199203000-00004. [DOI] [PubMed] [Google Scholar]
  40. Erdman S. H., Christensen R. D., Bradley P. P., Rothstein G. Supply and release of storage neutrophils. A developmental study. Biol Neonate. 1982;41(3-4):132–137. doi: 10.1159/000241541. [DOI] [PubMed] [Google Scholar]
  41. Falconer A. E., Carr R., Edwards S. W. Impaired neutrophil phagocytosis in preterm neonates: lack of correlation with expression of immunoglobulin or complement receptors. Biol Neonate. 1995;68(4):264–269. doi: 10.1159/000244245. [DOI] [PubMed] [Google Scholar]
  42. Fauser A. A., Messner H. A. Proliferative state of human pluripotent hemopoietic progenitors (CFU-GEMM) in normal individuals and under regenerative conditions after bone marrow transplantation. Blood. 1979 Nov;54(5):1197–1200. [PubMed] [Google Scholar]
  43. Freedman R. M., Ingram D. L., Gross I., Ehrenkranz R. A., Warshaw J. B., Baltimore R. S. A half century of neonatal sepsis at Yale: 1928 to 1978. Am J Dis Child. 1981 Feb;135(2):140–144. doi: 10.1001/archpedi.1981.02130260032010. [DOI] [PubMed] [Google Scholar]
  44. Frenck R. W., Jr, Buescher E. S., Vadhan-Raj S. The effects of recombinant human granulocyte-macrophage colony stimulating factor on in vitro cord blood granulocyte function. Pediatr Res. 1989 Jul;26(1):43–48. doi: 10.1203/00006450-198907000-00014. [DOI] [PubMed] [Google Scholar]
  45. Frenck R. W., Sarman G., Harper T. E., Buescher E. S. The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus. J Infect Dis. 1990 Jul;162(1):109–114. doi: 10.1093/infdis/162.1.109. [DOI] [PubMed] [Google Scholar]
  46. Gessler P., Kirchmann N., Kientsch-Engel R., Haas N., Lasch P., Kachel W. Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections. Blood. 1993 Nov 15;82(10):3177–3182. [PubMed] [Google Scholar]
  47. Gillan E. R., Christensen R. D., Suen Y., Ellis R., van de Ven C., Cairo M. S. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood. 1994 Sep 1;84(5):1427–1433. [PubMed] [Google Scholar]
  48. Gladstone I. M., Ehrenkranz R. A., Edberg S. C., Baltimore R. S. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J. 1990 Nov;9(11):819–825. doi: 10.1097/00006454-199011000-00009. [DOI] [PubMed] [Google Scholar]
  49. Halpérin D. S., Wacker P., Lacourt G., Félix M., Babel J. F., Aapro M., Wyss M. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr. 1990 May;116(5):779–786. doi: 10.1016/s0022-3476(05)82671-x. [DOI] [PubMed] [Google Scholar]
  50. Hensey O. J., Hart C. A., Cooke R. W. Serious infection in a neonatal intensive care unit: a two-year survey. J Hyg (Lond) 1985 Oct;95(2):289–297. doi: 10.1017/s0022172400062719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Hill H. R. Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res. 1987 Oct;22(4):375–382. doi: 10.1203/00006450-198710000-00001. [DOI] [PubMed] [Google Scholar]
  52. Horan T. D., English D., McPherson T. A. Association of neutrophil chemiluminescence with microbicidal activity. Clin Immunol Immunopathol. 1982 Feb;22(2):259–269. doi: 10.1016/0090-1229(82)90042-3. [DOI] [PubMed] [Google Scholar]
  53. Jaswon M. S., Jones H. M., Linch D. C. The effects of recombinant human granulocyte-macrophage colony stimulating factor on the neutrophil respiratory burst in the term and preterm infant when studied in whole blood. Pediatr Res. 1994 Nov;36(5):623–627. doi: 10.1203/00006450-199411000-00016. [DOI] [PubMed] [Google Scholar]
  54. Koenig J. M., Christensen R. D. Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. N Engl J Med. 1989 Aug 31;321(9):557–562. doi: 10.1056/NEJM198908313210901. [DOI] [PubMed] [Google Scholar]
  55. Laver J., Duncan E., Abboud M., Gasparetto C., Sahdev I., Warren D., Bussel J., Auld P., O'Reilly R. J., Moore M. A. High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates. J Pediatr. 1990 Apr;116(4):627–632. doi: 10.1016/s0022-3476(05)81617-8. [DOI] [PubMed] [Google Scholar]
  56. Lee S. M., Knoppel E., van de Ven C., Cairo M. S. Transcriptional rates of granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, interleukin-3, and macrophage colony-stimulating factor genes in activated cord versus adult mononuclear cells: alteration in cytokine expression may be secondary to posttranscriptional instability. Pediatr Res. 1993 Nov;34(5):560–564. doi: 10.1203/00006450-199311000-00002. [DOI] [PubMed] [Google Scholar]
  57. Liechty K. W., Schibler K. R., Ohls R. K., Perkins S. L., Christensen R. D. The failure of newborn mice infected with Escherichia coli to accelerate neutrophil production correlates with their failure to increase transcripts for granulocyte colony-stimulating factor and interleukin-6. Biol Neonate. 1993;64(5):331–340. doi: 10.1159/000244007. [DOI] [PubMed] [Google Scholar]
  58. Lieschke G. J., Cebon J., Morstyn G. Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor. Blood. 1989 Dec;74(8):2634–2643. [PubMed] [Google Scholar]
  59. Lieschke G. J., Maher D., O'Connor M., Green M., Sheridan W., Rallings M., Bonnem E., Burgess A. W., McGrath K., Fox R. M. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration. Cancer Res. 1990 Feb 1;50(3):606–614. [PubMed] [Google Scholar]
  60. Manroe B. L., Weinberg A. G., Rosenfeld C. R., Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr. 1979 Jul;95(1):89–98. doi: 10.1016/s0022-3476(79)80096-7. [DOI] [PubMed] [Google Scholar]
  61. Moore M. A. The clinical use of colony stimulating factors. Annu Rev Immunol. 1991;9:159–191. doi: 10.1146/annurev.iy.09.040191.001111. [DOI] [PubMed] [Google Scholar]
  62. Naparstek E. Granulocyte colony-stimulating factor, congenital neutropenia, and acute myeloid leukemia. N Engl J Med. 1995 Aug 24;333(8):516–518. doi: 10.1056/NEJM199508243330811. [DOI] [PubMed] [Google Scholar]
  63. Neumanaitis J. Granulocyte-macrophage-colony-stimulating factor: a review from preclinical development to clinical application. Transfusion. 1993 Jan;33(1):70–83. doi: 10.1046/j.1537-2995.1993.33193142315.x. [DOI] [PubMed] [Google Scholar]
  64. Ohls R. K., Christensen R. D. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr. 1991 Nov;119(5):781–788. doi: 10.1016/s0022-3476(05)80303-8. [DOI] [PubMed] [Google Scholar]
  65. Peden D. B., VanDyke K., Ardekani A., Mullett M. D., Myerberg D. Z., VanDyke C. Diminished chemiluminescent responses of polymorphonuclear leukocytes in severely and moderately preterm neonates. J Pediatr. 1987 Dec;111(6 Pt 1):904–906. doi: 10.1016/s0022-3476(87)80216-0. [DOI] [PubMed] [Google Scholar]
  66. Rapoport A. P., Abboud C. N., DiPersio J. F. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation. Blood Rev. 1992 Mar;6(1):43–57. doi: 10.1016/0268-960x(92)90007-d. [DOI] [PubMed] [Google Scholar]
  67. Richardson M. D., Brownlie C. E., Shankland G. S. Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF-activated human neutrophils. J Med Vet Mycol. 1992;30(6):433–441. [PubMed] [Google Scholar]
  68. Roberts R. L., Szelc C. M., Scates S. M., Boyd M. T., Soderstrom K. M., Davis M. W., Glaspy J. A. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor. Am J Dis Child. 1991 Jul;145(7):808–812. [PubMed] [Google Scholar]
  69. Rodwell R. L., Taylor K. M., Tudehope D. I., Gray P. H. Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns. Pediatr Infect Dis J. 1993 May;12(5):372–376. doi: 10.1097/00006454-199305000-00004. [DOI] [PubMed] [Google Scholar]
  70. Roilides E., Holmes A., Blake C., Venzon D., Pizzo P. A., Walsh T. J. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma. J Infect Dis. 1994 Oct;170(4):894–899. doi: 10.1093/infdis/170.4.894. [DOI] [PubMed] [Google Scholar]
  71. Rosenthal J., Healey T., Ellis R., Gillan E., Cairo M. S. A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life. J Pediatr. 1996 Jan;128(1):135–137. doi: 10.1016/s0022-3476(96)70443-2. [DOI] [PubMed] [Google Scholar]
  72. Russell A. R., Davies E. G., Ball S. E., Gordon-Smith E. Granulocyte colony stimulating factor treatment for neonatal neutropenia. Arch Dis Child Fetal Neonatal Ed. 1995 Jan;72(1):F53–F54. doi: 10.1136/fn.72.1.f53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Sacchi F., Rondini G., Mingrat G., Stronati M., Gancia G. P., Marseglia G. L., Siccardi A. G. Different maturation of neutrophil chemotaxis in term and preterm newborn infants. J Pediatr. 1982 Aug;101(2):273–274. doi: 10.1016/s0022-3476(82)80139-x. [DOI] [PubMed] [Google Scholar]
  74. Schibler K. R., Liechty K. W., White W. L., Christensen R. D. Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates. Blood. 1993 Oct 15;82(8):2478–2484. [PubMed] [Google Scholar]
  75. Schmitz N., Dreger P., Suttorp M., Rohwedder E. B., Haferlach T., Löffler H., Hunter A., Russell N. H. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood. 1995 Mar 15;85(6):1666–1672. [PubMed] [Google Scholar]
  76. Shannon K. M., Mentzer W. C., Abels R. I., Freeman P., Newton N., Thompson D., Sniderman S., Ballard R., Phibbs R. H. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr. 1991 Jun;118(6):949–955. doi: 10.1016/s0022-3476(05)82217-6. [DOI] [PubMed] [Google Scholar]
  77. Sullivan G. W., Carper H. T., Mandell G. L. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity. Blood. 1993 Apr 1;81(7):1863–1870. [PubMed] [Google Scholar]
  78. Toner G. C., Jakubowski A. A., Crown J. P., Meisenberg B., Sheridan C., Gabrilove J. L. Colony-stimulating factors and neutrophil migration. Ann Intern Med. 1989 May 15;110(10):846–847. doi: 10.7326/0003-4819-110-10-846. [DOI] [PubMed] [Google Scholar]
  79. Treweeke A. T., Aziz K. A., Zuzel M. The role of G-CSF in mature neutrophil function is not related to GM-CSF-type cell priming. J Leukoc Biol. 1994 May;55(5):612–616. doi: 10.1002/jlb.55.5.612. [DOI] [PubMed] [Google Scholar]
  80. Westwood N. B., Chung R., Emmerson A. J., Pearson T. C. The in vitro effects of stem cell factor, interleukin 3 and granulocyte-macrophage colony stimulating factor on haemopoietic progenitor cells from premature infants. Br J Haematol. 1994 Mar;86(3):468–474. doi: 10.1111/j.1365-2141.1994.tb04775.x. [DOI] [PubMed] [Google Scholar]
  81. Wheeler J. G., Chauvenet A. R., Johnson C. A., Dillard R., Block S. M., Boyle R., Abramson J. S. Neutrophil storage pool depletion in septic, neutropenic neonates. Pediatr Infect Dis. 1984 Sep-Oct;3(5):407–409. doi: 10.1097/00006454-198409000-00003. [DOI] [PubMed] [Google Scholar]
  82. Wheeler J. G., Givner L. B. Therapeutic use of recombinant human granulocyte-macrophage colony-stimulating factor in neonatal rats with type III group B streptococcal sepsis. J Infect Dis. 1992 May;165(5):938–941. doi: 10.1093/infdis/165.5.938. [DOI] [PubMed] [Google Scholar]
  83. Williams M. A., Kelsey S. M., Collins P. W., Gutteridge C. N., Newland A. C. Administration of rHuGM-CSF activates monocyte reactive oxygen species secretion and adhesion molecule expression in vivo in patients following high-dose chemotherapy. Br J Haematol. 1995 May;90(1):31–40. doi: 10.1111/j.1365-2141.1995.tb03377.x. [DOI] [PubMed] [Google Scholar]
  84. Wilson C. B. Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr. 1986 Jan;108(1):1–12. doi: 10.1016/s0022-3476(86)80761-2. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES